rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Wan-Shan Chen

Director

Company insider

Files Form 4 as: Director, Belite Bio.

Every Form 4 they filed

In numbers

Trades disclosed
4
Buys
0
Sells
1
Bought
$0
Sold
$397K
Companies
1
Companies where not an officer
1
First trade
31 Mar 2026
Last trade
9 Apr 2026
Last filed
13 Apr 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BLTE Belite BioDirector · Biotechnology · last 9 Apr 20260 buys · 1 sell

Activity over time

1 Apr – 1 Oct
10Apr 26Jun 26Jul 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Apr 2026filed 13 Apr 2026BLTE Belite BioBiotechnologySEC FORM 4 Sold$198K1,100 at $180.43filing
9 Apr 2026filed 13 Apr 2026BLTE Belite BioBiotechnologySEC FORM 4 Sold$198K1,100 at $180.43filing
31 Mar 2026filed 2 Apr 2026BLTE Belite Biooption or derivative · BiotechnologySEC FORM 4 Code A—13,796 at $0.00filing
31 Mar 2026filed 2 Apr 2026BLTE Belite Biooption or derivative · BiotechnologySEC FORM 4 Code A—13,796 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Hendrik Peter SchollChief Medical Officer · Chief Medical Officer at Belite Bio, filing Form 4 there in the last year
Yu-Hsin LinChief Executive Officer · Chief Executive Officer at Belite Bio, filing Form 4 there in the last year
Hao-Yuan ChuangChief Financial Officer · Chief Financial Officer at Belite Bio, filing Form 4 there in the last year
Nathan L. MataChief Scientific Officer · Chief Scientific Officer at Belite Bio, filing Form 4 there in the last year